Skip to content

Clinical Study of Endovascular Therapy in Patients with Posterior Circulation Occlusion

Clinical Study of Endovascular Therapy in Patients with Posterior Circulation Occlusion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121226
Enrollment
Unknown
Registered
2026-03-27
Start date
2026-03-09
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posterior circulation occlusion (vertebrobasilar occlusion), posterior circulation cerebral infarction

Interventions

Endovascular therapy group:None
Non-endovascular therapy group:None

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18 - 80 years old; 2. Meets the diagnostic criteria for posterior circulation ischemic stroke, with onset time <= 24 hours; 3. Imaging confirms occlusion of the intracranial segment of the vertebral artery or the basilar artery (CTA/MRA); 4. Planned for endovascular thrombectomy treatment, and the patient or their legal representative has signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severe bleeding tendency (such as coagulation dysfunction, active bleeding); 2. Severe underlying diseases (such as end-stage renal disease, advanced malignant tumors) with an expected survival period of less than 3 months; 3. Previous severe cognitive impairment (baseline MoCA score < 10); 4. Refusal to participate or inability to complete follow-up.

Design outcomes

Primary

MeasureTime frame
Rate of favorable cognitive outcome at 3 months after surgery;

Secondary

MeasureTime frame
Incidence of symptomatic intracranial hemorrhage;90-day all-cause mortality;Neurological functional outcome;The endpoint of surgical effectiveness;Refined assessment of cognitive function;Safety and no-reflow end points;Quality of life endpoint;

Countries

China

Contacts

Public ContactLe Weidong

The First Affiliated Hospital of Dalian Medical University

litianbai1@sina.com+86 411 83635963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026